The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NACLC 2022 | Key themes in lung cancer at NACLC 2022
Puneeth Iyengar, MD, PhD, UT Southwestern Medical Center, Dallas, TX, presents his highlights during the IASLC 2022 North America Conference on Lung Cancer (NACLC 2022). Key topics of interest included the increasing role of surgery in enhancing patient outcomes as well as integrating immunotherapy with surgery. Combining immunotherapy with chemotherapy has additionally been shown to provide favorable outcomes as shown in the Phase III PACIFIC trial (NCT02125461). This interview took place at NACLC 2022.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Puneeth Iyengar, MD, PhD, has received honoraria from Astrazeneca and Incyte.
